ST3GAL5 and breast cancer: Ganglioside GD2 was also identified as a putative marker of CD44hiCD24lo breast cancer stem cells (CSC) capable of initiating tumors, and several GT genes involved in GD2 biosynthesis (ST3GAL5, B4GALNT1, and ST8SIA1) are highly expressed in CSC [20].